2-(Chloromethyl)-6-methoxy-1H-benzo[d]imidazole

Catalog No. :
ACMCBI403
CAS No. :
14625-40-2
Molecular Formula :
C9H9ClN2O
Molecular Weight :
196.64

IUPAC Name:2-(chloromethyl)-5-methoxy-1H-benzo[d]imidazole

2-(Chloromethyl)-6-methoxy-1H-benzo[d]imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$243.00Login to see priceInquiryInquiry
100mg97%$354.00Login to see priceInquiryInquiry
250mg97%$498.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Chloromethyl)-6-methoxy-1H-benzo[d]imidazole
IUPAC Name2-(chloromethyl)-5-methoxy-1H-benzo[d]imidazole
MDL No.MFCD09743313
Molecular FormulaC9H9ClN2O
Molecular Weight196.64
SMILESCOC1=CC=C2C(NC(CCl)=N2)=C1
InChI KeyWZEWEZMUYDNMCZ-UHFFFAOYSA-N
Synonym2-(CHLOROMETHYL)-6-METHOXY-1H-BENZO[D]IMIDAZOLE;1H-Benzimidazole,2-(chloromethyl)-5-methoxy-(9CI);1H-Benzimidazole, 2-(chloromethyl)-6-methoxy-;2-(Chloromethyl)-6-methoxy-1H-1,3-benzodiazole
CAS No.14625-40-2

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACMCBI403 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCES692 route compound structure diagram
    ACBCES69220033-99-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMCBI403 route product structure diagram
    ACMCBI40314625-40-2
Inquiry

2. ACMCBI403 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFICY014 route compound structure diagram
    ACFICY01459548-39-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMCBI403 route product structure diagram
    ACMCBI40314625-40-2
Inquiry

Comments (0)